Gilead Sciences

Open: 77.82 Close: 77.72 Change: -0.1

Our AI found some flaws in Gilead Sciences Company Inc Stock.

How much time have you spent trying to decide whether investing in Gilead Sciences? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Gilead Sciences are: …

Concept Map

Semantic Network

Stock Summary

Gilead Sciences, Inc. discovers, develops, and commercializes medicines in the areas of unmet medical need. The company provides Biktarvy, Genvoya, Descovy, Descogna, Odefsey,.

Today's Summary

Gilead Sciences (NASDAQ:GILD) Is Paying Out a Larger Dividend than last year. The company has been growing its dividend at a decent rate, and the payments have been stable.

Today's News

Gilead Sciences (NASDAQ:GILD) Is Paying Out A Larger Dividend Than Last Year. The company has been growing its dividend at a decent rate, and the payments have been stable. We think this could be an attractive income stock. Gilead Sciences (NASDAQ:GILD) is favoured by institutional owners who hold 85% of the company. The European Commission (EC) will review the CHMP recommendation and, if adopted, Veklury will become the first and only authorized antiviral COVID-19 treatment. Gilead Sciences to Present at Upcoming June 2023 Investor Conference. CHMP Adopts Positive Opinion to Extend the Use of Veklury® (Remdesivir) to Treat COVID-19. Gilead Sciences announced… Story temporarily locked. Gilead Sciences Inc. offers GILEAD SCIENCES 401(K) PLAN through Fidelity. Get help rolling your 401(k) plan into an IRA of your choosing. Gilead Sciences stock price is 77.89 USD today. How to buy stock online? You can buy shares by opening an account at a top tier brokerage firm. Gilead Sciences recently partnered with Roche on May 5, 2023. The increase was primarily driven by two charges in the fourth quarter of 2021 which did not recur in 2022. The $1.25 billion charge for a legal settlement and the $ 625 million charge for the Arcus Biosciences.

Stock Profile

"Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California."

Keywords

Are looking for the most relevant information about Gilead Sciences? Investor spend a lot of time searching for information to make investment decisions in Gilead Sciences. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Gilead Sciences are: Gilead, Sciences, stock, charge, NASDAQGILD, company, CHMP, and the most common words in the summary are: gilead, science, report, stock, street, inc, therapeutic, . One of the sentences in the summary was: The company has been growing its dividend at a decent rate, and the payments have been stable.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #gilead #science #report #stock #street #inc #therapeutic.